その他、買掛金、研究開発費 - 化成品他2件
- 【期間】
| 年度 | その他 | 買掛金 | 研究開発費 - 化成品 | 貸倒損失 | 負債の部合計 |
|---|
| 2008/03 | 87.6億 | | 289億 | | - | | - | | 1771億 | |
| 2009/03 | 99.1億 | +13.2% | 195億 | -32.7% | - | | - | | 2139億 | +20.7% |
| 2010/03 | 108億 | +8.7% | 231億 | +18.4% | - | | - | | 2093億 | -2.1% |
| 2011/03 | 335億 | +210.7% | 234億 | +1.6% | - | | 15.7億 | | 2271億 | +8.5% |
| 2012/03 | 195億 | -41.7% | 268億 | +14.3% | - | | - | | 2457億 | +8.2% |
| 2013/03 | 137億 | -29.7% | 243億 | -9.4% | - | | 0.61億 | -96.1% | 2944億 | +19.8% |
| 2014/03 | 62.6億 | -54.3% | 246億 | +1.2% | - | | 4.79億 | +685.2% | 3399億 | +15.5% |
| 2015/03 | 40.2億 | -35.9% | 240億 | -2.2% | - | | - | | 3851億 | +13.3% |
| 2016/03 | 41.9億 | +4.4% | 227億 | -5.4% | - | | - | | 3411億 | -11.4% |
| 2017/03 | 32.2億 | -23.1% | 224億 | -1.4% | - | | - | | 2885億 | -15.4% |
| 2018/03 | 31.6億 | -1.8% | 312億 | +39.4% | - | | - | | 2254億 | -21.9% |
| 2019/03 | 36.2億 | +14.5% | 292億 | -6.4% | 279百万 | | - | | 2161億 | -4.1% |
| 2020/03 | 43.8億 | +21% | 293億 | +0.2% | - | | 11.2億 | +133.6% | 2030億 | -6.1% |
| 2021/03 | 48.5億 | +10.8% | 283億 | -3.5% | - | | - | | 1815億 | -10.6% |
| 2022/03 | 50.8億 | +4.6% | 378億 | +33.8% | - | | - | | 2003億 | +10.3% |
| 2023/03 | 47.8億 | -5.9% | 379億 | +0.3% | - | | - | | 2367億 | +18.2% |
| 2024/03 | 45.2億 | -5.3% | - | | - | | - | | 1974億 | -16.6% |
